The long-term goal of the Boeckh Research Program is to prevent infectious disease in immunocompromised hosts and reduce the severity of infections that do occur. We focus on herpes viruses (primarily cytomegalovirus and human herpes virus 6), respiratory viruses, and the genetics of susceptibility to infection.
The following trials are presently being conducted by Dr. Boeckh’s Group.